Researchers at Keck School of Medicine of USC identify a novel target related to the blood-brain barrier and a potential therapy that offers hope for slowing progression of ... Read More »
Paul Aisen, MD, director of the Alzheimer’s Therapeutic Research Institute (ATRI) of the Keck School of Medicine at USC, will oversee a study of a new drug in ... Read More »
If it’s confirmed that a drug can remove memory-stealing plaques from the brain before the damage from Alzheimer’s disease is already done, “we may really change the course ... Read More »
Colored light micrograph of brain tissue from an Alzheimer's disease sufferer. Both of the classic pathological features of this disease are seen here. Both of these abnormalities ... Read More »
An online tool that helps older people monitor their brain health has been developed at the Keck School of Medicine of USC with other medical groups.
In partnership with the Alzheimer Disease Research Center of USC, Hussein Yassine, MD, assistant professor of medicine at the Keck School of Medicine of USC, was awarded two ... Read More »
Twice as many women as men develop Alzheimer’s disease, but even after years of research, aging experts are unsure why. Judy Pa, PhD, assistant professor of neurology at ... Read More »
